|Catherine A. Sazdanoff|
Catherine A. Sazdanoff is the Chief Business Officer of Strata Oncology, Inc., a precision oncology company, where she is responsible for business and corporate development, marketing, public relations, and legal functions. She is also a member of the Advisory Board of Neurocern, Inc., a dementia management company. Immediately prior to taking her Strata Oncology role in June 2016, Ms. Sazdanoff was CEO and President of Sazdanoff Consulting LLC, specializing in business development, management and strategy consulting, and she was a Strategic Advisor to mProve Health LLC, a mobile health technology company. From 2006 to 2015, Ms. Sazdanoff held a number of executive positions with Takeda Pharmaceutical International, Inc. including Vice President, Head of Corporate Projects, VP, Global Business Development and VP, Corporate Development. Prior to her time at Takeda, Ms. Sazdanoff spent 22 years with Abbott Laboratories, where she held numerous executive positions. Ms. Sazdanoff received a B.A. from the University of Notre Dame and a J.D. from Northwestern University School of Law.